Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) open the trading on Wednesday, with a bit cautious approach as it glided -3.81% to $0.24, before settling in
A new trading day began on Friday, with Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) stock price up 3.40% from the previous day of trading, before
On Tuesday, Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) was -12.01% drop from the session before settling in for the closing price of $0.26. A 52-week
Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) open the trading on Thursday, with great promise as it jumped 6.20% to $0.32, before settling in for the
On Monday, Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) was -4.37% drop from the session before settling in for the closing price of $0.21. A 52-week
As on Thursday, Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) started slowly as it slid -4.37% to $0.22, before settling in for the price of $0.23
Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) kicked off on Monday, down -4.81% from the previous trading day, before settling in for the closing price of
Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) open the trading on Thursday, with a bit cautious approach as it glided -37.65% to $0.28, before settling in
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
